0001209191-19-054333.txt : 20191029
0001209191-19-054333.hdr.sgml : 20191029
20191029165456
ACCESSION NUMBER: 0001209191-19-054333
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191025
FILED AS OF DATE: 20191029
DATE AS OF CHANGE: 20191029
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 191176422
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-25
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Patient Officer
Common Stock
2019-10-25
4
M
0
4311
91.05
A
37727
D
Common Stock
2019-10-25
4
S
0
4311
195.01
D
33416
D
Common Stock
882
I
401(k)
Common Stock
18964
I
Held in trust
Stock Option (Right to Buy)
91.05
2019-10-25
4
M
0
4311
0.00
D
2026-02-01
Common Stock
4311
4311
D
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $195.01 (range $195.00 to $195.04).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
The option vests in 16 quarterly installments from 02/02/2016.
/s/ Omar White, Attorney-in-Fact
2019-10-29